You have 7 free searches left this month | for more free features.

induction regimen

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in Canada (Busulfan, Melphalan, Lenalidomide)

Completed
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +9 more
Sep 20, 2022

Arthritis, Rheumatoid Trial in Belgium (Etanercept 50 MG/ML, Leflunomide 10 milligram (MG))

Completed
  • Arthritis, Rheumatoid
  • Etanercept 50 MG/ML
  • Leflunomide 10 milligram (MG)
  • Bonheiden, Antwerpen, Belgium
  • +18 more
Jul 4, 2022

HIV, Burkitt's Lymphoma Trial in Italy (Induction Phase, Consolidation Phase (on day +50), Intensification phase)

Completed
  • HIV
  • Burkitt's Lymphoma
  • Induction Phase
  • +4 more
  • Aviano (PN), Italy
  • +7 more
Aug 2, 2022

Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

Recruiting
  • Sickle Cell Disease
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jul 6, 2022

Polymyalgia Rheumatica Trial in Graz, Wien (Tocilizumab Prefilled Syringe [Actemra], Placebos, Glucocorticoids)

Completed
  • Polymyalgia Rheumatica
  • Tocilizumab Prefilled Syringe [Actemra]
  • +2 more
  • Graz, Austria
  • +2 more
Jan 20, 2021

Eosinophilic Granulomatosis With Polyangiitis (EGPA) Trial in Paris (Rituximab, Placebo-rituximab, Cyclophosphamide)

Completed
  • Eosinophilic Granulomatosis With Polyangiitis (EGPA)
  • Paris, France
    Hôpital Cochin
Apr 13, 2021

Locally Advanced Malignant Tumor, Rectal Carcinoma Trial in France (drug, other, radiation, procedure)

Recruiting
  • Locally Advanced Malignant Neoplasm
  • Rectal Carcinoma
  • Induction chemotherapy - modified FOLFIRINOX regimen
  • +3 more
  • Besançon, Doubs, France
  • +18 more
Jan 2, 2022

Venous Thromboembolism Trial in Valencia (Apixaban 2.5 MG)

Terminated
  • Venous Thromboembolism
  • Apixaban 2.5 MG
  • Valencia, Spain
  • +3 more
Feb 12, 2021

Locally Advanced Head and Neck Carcinoma Trial (docetaxel, cisplatin, fluorouracil)

Completed
  • Locally Advanced Head and Neck Carcinoma
  • docetaxel, cisplatin, fluorouracil
  • (no location specified)
May 17, 2020

Acute Myeloid Leukemia Trial in Suzhou (IAC regimen, High-dose IA regimen, Intermediate-dose IA regimen)

Recruiting
  • Acute Myeloid Leukemia
  • IAC regimen
  • +2 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Feb 3, 2020

Breast Cancer, Brain Metastases Trial in Taiwan (BEEP regimen)

Active, not recruiting
  • Breast Cancer
  • Brain Metastases
  • BEEP regimen
  • Kaohsiung, Taiwan
  • +7 more
May 6, 2021

Acute Myeloid Leukemia Trial in Tianjin (Different induction chemo regimens)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Different induction chemotherapy regimens
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Sep 27, 2023

Bladder Cancer Trial in Mansoura (induction regimen of intravesical BCG)

Completed
  • Bladder Cancer
  • induction regimen of intravesical BCG
  • Mansoura, Egypt
    Urology and Nephrology Center
Mar 24, 2020

Lymphoma, Lymphoblastic Trial in GuangZhou (induction phase1, induction phase2, protocol M)

Unknown status
  • Lymphoma, Lymphoblastic
  • induction phase1
  • +6 more
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 31, 2020

Gastric Cancer, Chemo Effect, Immune Checkpoint Inhibitor Trial in Shanghai (Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU)

Recruiting
  • Gastric Cancer
  • +2 more
  • Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 1, 2023

Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

Recruiting
  • Refractory/Relapse Acute Myeloid Leukemia
  • Kunming, Yunnan, China
    Department of Hematology,920th Hospital of Joint Logistic Suppor
Mar 28, 2023

Bortezomib, Acute Myeloid Leukemia Trial in Wuhan (DAG pre-excitation regimen with Bortezomib)

Recruiting
  • Bortezomib
  • Acute Myeloid Leukemia
  • DAG pre-excitation regimen with Bortezomib
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 31, 2023

B-cell Acute Lymphoblastic Leukemia Trial in United States (Inotuzumab ozogamicin, Prednisone Pill, Daunorubicin)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Inotuzumab ozogamicin
  • +6 more
  • Nashville, Tennessee
  • +3 more
Aug 14, 2022

Avacostar - (PASS)

Not yet recruiting
  • ANCA-associated Vasculitis
    • (no location specified)
    Jun 12, 2023

    Induction of Labour With Misoprostol Trial in Lahore (Misoprostol Oral Tablet, vaginal misoprostol)

    Recruiting
    • Induction of Labour With Misoprostol
    • Misoprostol Oral Tablet
    • vaginal misoprostol
    • Lahore, Punjab, Pakistan
      Services Institute Of Medical Sciences
    Jul 15, 2023

    Crohn Disease Trial (selective intensive induction therapy based on ustekinumab clinical decision-making tools)

    Not yet recruiting
    • Crohn Disease
    • selective intensive induction therapy based on ustekinumab clinical decision-making tools
    • (no location specified)
    May 6, 2023

    CNS Germ Cell Tumor Trial in United States (Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx).)

    Completed
    • CNS Germ Cell Tumor
    • Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx).
    • Phoenix, Arizona
    • +4 more
    Jan 5, 2021

    Acute Myeloid Leukemia Trial in Italy (Venetoclax)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Bergamo, Italy
    • +21 more
    Jan 9, 2023

    De Novo Kidney Transplant Patients Trial in China (ATG-F)

    Completed
    • De Novo Kidney Transplant Patients
    • Beijing, China
    • +13 more
    Jul 26, 2022